Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11015306 | 0.98 | KMT2A (0.32) | KMT2AMEN1ALDH1A1RECQL | |
| SCHEMBL8915279 | 0.82 | ALDH1A1 (0.35) | KMT2AMEN1ALDH1A1 | |
| SCHEMBL11012718 | 0.81 | MEN1 (0.36) | KMT2AMEN1ALDH1A1RECQL | |
| SCHEMBL6908302 | 0.80 | MEN1 (0.38) | KMT2AMEN1 | |
| SCHEMBL10765977 | 0.80 | MEN1 (0.38) | KMT2AMEN1 | |
| SCHEMBL28323877 | 0.80 | MEN1 (0.38) | KMT2AMEN1 | |
| SCHEMBL23015039 | 0.80 | KMT2A (0.47) | KMT2AMEN1ALDH1A1RECQL | |
| SCHEMBL9000238 | 0.80 | KMT2A (0.47) | KMT2AMEN1ALDH1A1RECQL | |
| SCHEMBL11823754 | 0.80 | KMT2A (0.47) | KMT2AMEN1ALDH1A1RECQL | |
| SCHEMBL6819838 | 0.80 | KMT2A (0.47) | KMT2AMEN1ALDH1A1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9829487-B2 | Self-assembled monolayers and methods for using the same in biosensing applications | NUTECH VENTURES (US) | 2017-11-28 | — | — | US | disclosed |
| US-20160047803-A1 | SELF-ASSEMBLED MONOLAYERS AND METHODS FOR USING THE SAME IN BIOSENSING APPLICATIONS | NUTECH VENTURES | 2016-02-18 | — | — | US | disclosed |
| US-9079835-B2 | Self-assembled monolayers and methods for using the same in biosensing applications | NUTECH VENTURES (US) | 2015-07-14 | — | — | US | disclosed |
| US-20120315625-A1 | SELF-ASSEMBLED MONOLAYERS AND METHODS FOR USING THE SAME IN BIOSENSING APPLICATIONS | NATIONAL SCIENCE FOUNDATION | 2012-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120315625-A1 | SELF-ASSEMBLED MONOLAYERS AND METHODS FOR USING THE SAME IN BIOSENSING APPLICATIONS | SPR, SAMSN1, NAPA | KMT2A 4306/4885MEN1 2961/4885ALDH1A1 2389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.